Referencias

  1. Ikeda K, Clark JC, Shaw-White JR, Stahlmann MT, Boutell CJ, Whitsett JA. Gene structure and expresión of human thyroid transcription factor-1 in respiratory epithelial cells. J Biol Chem 1995, 270: 8108-8114.
  2. Whitsett JA, Glasser SW. Regulation of surfactant protein gene transcription. Biochem Biphys Acta 1998, 1408: 303-311.
  3. Fabbro D, Di Loreto C, Beltrami CA, Belfiore A, Di Lauro R, Damante G. Expresión of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms. Cancer Res 1994, 54: 4744-4749.
  4. Fabbro D, Di Loreto C, Stamerra O, Beltrami CA, Lonigro R, Damante G. TTF-1 gene expresión in human lung tumors. Europ J Cancer 1996, 32 A: 512-517.
  5. Di Loreto C, Di Lauro V, Puglisi F, Damante G, Favor D, Beltrami CA. Immunocytochemical expresión of tissue specific transcription factor-1 in lung carcinoma. J Clin Pathol 1997, 50: 30-32.
  6. García Tamayo J, Hernández C. La inmunohistoquímica en el cáncer metastático. Vitae Academia Biomédica Digital, 2002, Vol 14. http://caibco.ucv.ve/Vitae/VitaeCatorce/Articulos/AnatomiaPatologica/
  7. Shih LY, Chen TH, Lo WH. Skeletal metastasis from occult carcinoma. J Surg Oncol 1992, 51: 109-113.
  8. Leonard RJ, Nystrom JS. Diagnostic evaluation of patients with carcinoma of unknown primary tumor site. Semin Oncol 1993, 20: 244-250.
  9. Kimura S, Ward J, Minoo P. Thyroid-specific enhancer-binding protein/thyroid transcription is not required for initial specification of the thyroid and lung primordia. Biochimie 1999, 81: 321-327.
  10. Zhang L, Withsett J, Stripp B. Regulation of Clara cells secretory protein gene transcription by thyroid factor -1. Biochem Biophys Acta 1997, 1350: 359-367.
  11. Raab SS, Berg LC, Swanson PE, Wick MR. Adenocarcinoma in the lung in patients with breast cancer. Apospective analysis of the discriminatory value of immunohistology. Am J Clin Pathol 1993, 100:27-35.
  12. Bedrossian CW, Bonsib S, Moran C. Differential diagnosis between mesotelioma and adenocarcinoma: a multimodal approach based on ultrastructure and immunocytochemistry. Sem in Diag Pathol 1992, 9: 124-140
  13. Hasleton P, King J. Malignant pleural Mesothelioma. Curr Diag Pathol 1999, 5: 991-1005
  14. García Tamayo J, Hernández C. Algunas consideraciones sobre la inmunohistoquímica en el diagnóstico diferencial entre Mesotelioma y Adenocarcinoma. Vitae Academia Biomédica Digital, 2002, Vol 13, http://caibco.ucv.ve/Vitae/VitaeTrece/Articulos/AnatomiaPatologica/
  15. Ordoñez NG. Value of Thyroid Transcription Factor-1 immunostaining in distinghising Small Cell Lung carcinomas from other Small Cell carcinomas. Am J Surg Pathol 2000, 24:1217-1223.
  16. McDowell EM, McLaughlin JS, Merrenyl D,K, Kieffer RF, Harris CC. The respiratory epithelium.V. Histogenesis of lung carcinomas in the human. J Nat Cancer Inst 1978, 61:587-606.
  17. Churg A. The fine structure of Large Cell undifferentiated carcinoma of the lung. Human Pathology 1978, 9: 143-156.
  18. García Tamayo J. Aspectos ultraestructurales de la patología tumoral. Invest Clin 1982, 3: 123 - 215.
  19. Chu PG, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 2000, 13: 962 - 972.
  20. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: pattern of expression in normal epithelia, tumor and culture cells. Cell 1982, 31: 11 - 24.
  21. Wieneke J, ThompsonL, Weing B. Basaloid squamous cella carcinoma of the sinonasal tract. Cancer 1999, 85:841-854.
  22. Sturm N, Lantuejoul S, Laverrie MH, Papotti M, Brichon PY, Brambilla C, Brambilla E. Thyroid Transcription Factor 1 and Cytokeratins 1,5,10,14 ( 34B E12) expresión in Basaloid and Large-Cell Neuroendocrine carcinomas of the lung. Human Pathol 2001, 32:n918-925.
  23. Kauffmann O, Dietel M. Expression of thyroid transcription factor-1 in pulmomary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites. Histopathology 2000, 36:415-420.
  24. Nassar H, Wallis T, Andea A y col. Clinicopathologic analysis of invasive micropapillary differentiation in breast carcinoma. Mod Pathol 2001, 14: 836-841.
  25. Miyoshi T,Satch Y,Okomura S,Nakagawa K y col. Early stage lung adenomas with micropapillary pattern. A distinct pathology marker for a significantly poor prognosis. Am J Surg Pathol 2003, 27: 101-109.
  26. Amin MB, Tamboli P, Merchant SH y col. Micropapillary component in lung adenocarcinoma: a distinctive histologic feature with possible prognostic significance. Am J Surg Pathol 2002, 26: 358-364.
  27. Bell KA, Sehdev S, Kurman RS. Redefined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumos (borderline ) and micropapillary serous carcinomas. Am J Surg Pathol 2001, 25: 419-432.
  28. Silver SA, Askin FB. True papillary carcinoma of the lung. Am J Surg Pathol 1997, 21:43-51.
  29. Lucas DR, Pass HI, Madan SK y col. Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study. Histopathology 2003, 42:270-279.
  30. Rossi G, Cavazza A, Sturm N, Migaldi M y col. Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements. A clinicopathologic and ultrastructural study of 75 cases. Am J Surg Pathol 2003, 27:311-324.